Lung cancer artificial olfactory system
The LCAOS project will develop and test a new diagnostic tool, able to detect: (I) the presence of lung cancer (LC), and (II) an increased risk of a patient developing LC in the future. Diagnostic tests currently available are unsuitable for widespread screening because they are costly, occasionally miss tumors, are not time-efficient, nor free of complications. LCAOS will overcome these problems by using an approach based on volatile biomarkers emitted from cell membranes.
More information can be found on the project website http://www.lcaos.eu/
The research receives funding from the FP7-Health Program (grant agreement no. 258868).